Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAUSCH

  • FDA Approval
  • May 07, 2024, 21:35 UTC
  • 39
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • May 07, 2024, 21:35 UTC
  • 39
  • 0 comments

FDA approve BUPROPION HYDROBROMIDE

Comment Full text

GLAXOSMITHKLINE

  • FDA Approval
  • May 07, 2024, 21:35 UTC
  • 35
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

TWI PHARMS

  • FDA Approval
  • May 07, 2024, 20:43 UTC
  • 45
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

NALPROPION

  • FDA Approval
  • May 07, 2024, 20:43 UTC
  • 46
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • May 07, 2024, 09:10 UTC
  • 44
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

LEXENPHARM

  • FDA Approval
  • May 07, 2024, 09:10 UTC
  • 38
  • 0 comments

FDA approve ALBUTEROL SULFATE

Comment Full text

MYLAN

  • FDA Approval
  • May 07, 2024, 09:10 UTC
  • 43
  • 0 comments

FDA approve LANSOPRAZOLE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • May 07, 2024, 09:10 UTC
  • 45
  • 0 comments

FDA approve ROPINIROLE HYDROCHLORIDE

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • May 07, 2024, 09:10 UTC
  • 35
  • 0 comments

FDA approve FLUOROESTRADIOL F-18

Comment Full text
  • Previous
  • 457
  • 458
  • 459
  • 460
  • 461
  • Next

Search

News categories

  • Technical Exchange News(11662)
  • Event(3929)
  • SEC News(228708)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(141063)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin